Sotera Health Company $SHC Shares Acquired by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. increased its position in Sotera Health Company (NASDAQ:SHC) by 5.1% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,415,282 shares of the company’s stock after acquiring an additional 68,087 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.50% of Sotera Health worth $16,502,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the company. XTX Topco Ltd acquired a new stake in shares of Sotera Health in the 1st quarter worth approximately $602,000. Victory Capital Management Inc. grew its holdings in shares of Sotera Health by 5.7% in the 1st quarter. Victory Capital Management Inc. now owns 57,655 shares of the company’s stock worth $672,000 after acquiring an additional 3,106 shares during the period. Principal Financial Group Inc. grew its holdings in shares of Sotera Health by 0.3% in the 1st quarter. Principal Financial Group Inc. now owns 352,388 shares of the company’s stock worth $4,109,000 after acquiring an additional 1,037 shares during the period. Teacher Retirement System of Texas acquired a new stake in shares of Sotera Health in the 1st quarter worth approximately $266,000. Finally, New York State Teachers Retirement System grew its holdings in shares of Sotera Health by 1.9% in the 1st quarter. New York State Teachers Retirement System now owns 59,273 shares of the company’s stock worth $691,000 after acquiring an additional 1,100 shares during the period. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Price Performance

SHC stock opened at $16.43 on Friday. Sotera Health Company has a 52-week low of $9.53 and a 52-week high of $17.08. The stock’s fifty day simple moving average is $12.35 and its 200-day simple moving average is $12.18. The company has a quick ratio of 2.23, a current ratio of 2.47 and a debt-to-equity ratio of 4.49. The stock has a market capitalization of $4.67 billion, a price-to-earnings ratio of 205.40 and a beta of 1.81.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Friday, August 8th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.03. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%.The business had revenue of $294.34 million for the quarter, compared to analysts’ expectations of $275.81 million. During the same quarter last year, the firm earned $0.19 earnings per share. The business’s revenue was up 6.4% on a year-over-year basis. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. Equities research analysts expect that Sotera Health Company will post 0.61 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. The Goldman Sachs Group upgraded Sotera Health from a “neutral” rating to a “buy” rating and increased their target price for the company from $14.00 to $17.00 in a report on Monday, May 5th. Wall Street Zen upgraded Sotera Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 16th. Finally, Barclays reiterated an “overweight” rating on shares of Sotera Health in a report on Friday, August 8th. Four investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $16.00.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.